Article
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.
Scientific reports - 7 Jan 2022
Karunasinghe Nishi, Minas Tsion Zewdu, Bao Bo-Ying, Lee Arier, Wang Alice, Zhu Shuotun, Masters Jonathan, Goudie Megan, Huang Shu-Pin, Jenkins Frank J, Ferguson Lynnette R
Abstract excerpt
It is being debated whether prostate-specific antigen (PSA)-based screening effectively reduces prostate cancer mortality. Some of the uncertainty could be related to deficiencies in the age-based PSA cut-off thresholds used in screening. Current study considered 2779 men with prostate cancer and 1606 men without a cancer diagnosis, recruited for various studies in New Zealand, US, and Taiwan. Association of PSA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
